U.S. Food and Drug Administration | Facebook
Links shared publicly online about this topic.
- 722total visits
U.S. Food and Drug Administration | Facebook
View full resource at facebook.com
Tags: Drug, Pharma, FDA, #HCSM, #HCSMEU
Most Recently Shared on November 17, 2010 at 1:02 am By:
RT @iDailyScoop: #FDA on Fb http://on.fb.me/aagj05 Comment Policy" tab is glimpse of much needed pharma guidance policy #hcsmeu #hcsm
FDA approves Stendra for erectile dysfunction
fda.gov — “The U.S. Food and Drug Administration today approved Stendra (avanafil), a new drug to treat erectile dysfunction.” View full resource at fda.gov
Most Recently Shared on April 27, 2012 at 6:59 pm By:
eyeonfda Pharma and Health Lawyer
#FDA issues press release about approval of Vivus ED drug Stendra - http://t.co/deRucBA2
FDA strengthens international collaboration to ensure quality, safety of imported products | diabetes and more | Scoop.it
scoop.it — “The U.S. Food and Drug Administration Commissioner Margaret A. Hamburg, M.D. today released the agency’s “Global Engagement Report,” detailing the many activities and strategies FDA is using to transform from a domestic to a global public health agency. The report describes the steps the agency is taking to ensure that imported food, drugs, medical devices, and other regulated products meet the same rigorous standards for safety and quality as those manufactured domestically...” View full resource at scoop.it
Most Recently Shared on April 26, 2012 at 11:14 am By:
FDA strengthens international collaboration to ensure quality, safety of imported products | @scoopit http://t.co/fIaoJJ1b
AIDSmeds - Top Stories : Report Outlines HIV Cure Research, Important Gaps - by Tim Horn
aidsmeds.com — “Three HIV/AIDS activist groups convened a meeting in March with researchers and representatives of the U.S. Food and Drug Administration (FDA) to describe the current state of cure research and identify barriers to moving such research forward swiftly and smoothly. The proceedings of this meeting, which took place immediately before the 19th Conference on Retroviruses and Opportunistic Infections (CROI) that began on March 5 in Seattle, are now available in a report online.” View full resource at aidsmeds.com
Most Recently Shared on April 25, 2012 at 9:52 pm By:
Top Stories : Report Outlines #HIV #Cure Research, Important Gaps http://t.co/8Oyn9MYq #AIDS @projectinform @tagteam_tweets #atac
Ironwood faces 3-month FDA delay for potential IBS drug linaclotide - Boston Business Journal
bizjournals.com — “Ironwood Pharmaceuticals Inc. (Nasdaq: IRWD) and its partner Forest Laboratories Inc. (NYSE: FRX) have announced the U.S. Food and Drug Administration will delay its approval decision for the companies’ potential drug for irritable bowel syndrome (IBS), called linaclotide.” View full resource at bizjournals.com
Most Recently Shared on April 24, 2012 at 7:18 pm By:
Inflammatory Bowel Syndrome OW Health
Ironwood faces 3-month FDA delay for potential IBS drug linaclotide: Ironwood Pharmaceuticals Inc. (Nasdaq: IRWD... http://t.co/l5H6RRmq
FDA approves i-Lipo fat-reduction device - - ModernMedicine
modernmedicine.com — “The Food and Drug Administration has cleared the i-Lipo (Chromogenex), a low-level laser diode fat-reduction device for body contouring, for U.S. marketing.” View full resource at modernmedicine.com
Most Recently Shared on April 23, 2012 at 5:45 am By:
CosmeticSurgeryTimes Medical Journal
FDA approves i-Lipo fat-reduction device http://t.co/hgpzSl8W #plasticsurgery
FDA says focused on tracking drugs after approval | Reuters
reuters.com — “ATLANTA (Reuters) - The U.S. Food and Drug Administration said on Saturday it now spends as much effort and resources on surveilling a drug after it is approved as it does in the pre-approval process.The” View full resource at reuters.com
Most Recently Shared on April 22, 2012 at 3:26 am By:
Tom Heston, MD Doctor, Family Medicine Doctor, and Physician
FDA says focused on tracking drugs after approval - Reuters http://t.co/S8Ty5Smt #medicine
FDA says focused on tracking drugs after approval | Reuters
reuters.com — “ATLANTA (Reuters) - The U.S. Food and Drug Administration said on Saturday it now spends as much effort and resources on surveilling a drug after it is approved as it does in the pre-approval process.The” View full resource at reuters.com
Most Recently Shared on April 22, 2012 at 12:20 am By:
Brad Lipson, DO Family Medicine Doctor, Physician, Active Health Library, and Doctor
FDA says focused on tracking drugs after approval: ATLANTA (Reuters) - The U.S. Food and Drug Administration sai... http://t.co/tyVaedT1
FDA says focused on tracking drugs after approval | Reuters
reuters.com — “ATLANTA (Reuters) - The U.S. Food and Drug Administration said on Saturday it now spends as much effort and resources on surveilling a drug after it is approved as it does in the pre-approval process.The” View full resource at reuters.com
Most Recently Shared on April 21, 2012 at 8:47 pm By:
FDA says focused on tracking drugs after approvalReutersBy Debra Sherman | ATLANTA (Reuters) - The US Food and D... http://t.co/JNtAA8e4
Report: FDA strengthens monitoring of post-approval drug safety
fda.gov — “A strengthened and modernized postmarket drug safety program has resulted in a substantial improvement in the U.S. Food and Drug Administration’s oversight of drugs once they reach the American public, according to a new report released today by the agency’s Center for Drug Evaluation and Research (CDER). The report, “Advances in FDA’s Safety Program for Marketed Drugs,” describes new scientific tools and enhanced capabilities that give the same priority to postmarket drug safety monitoring as t” View full resource at fda.gov
Most Recently Shared on April 21, 2012 at 8:42 pm By:
HealthTrendster Health Executive
Report: FDA strengthens monitoring of post-approval drug safety: A strengthened and… http://t.co/Nlax6RLR
FDA says focused on tracking drugs after approval | Reuters
reuters.com — “ATLANTA (Reuters) - The U.S. Food and Drug Administration said on Saturday it now spends as much effort and resources on surveilling a drug after it is approved as it does in the pre-approval process.The” View full resource at reuters.com
Most Recently Shared on April 21, 2012 at 8:30 pm By:
Brad Lipson, DO Family Medicine Doctor, Physician, Active Health Library, and Doctor
FDA says focused on tracking drugs after approval: ATLANTA (Reuters) - The U.S. Food and Drug Administration sai... http://t.co/a47c8atr
Medical Innovation Program Starts With The Kidneys
huffingtonpost.com — “* FDA plan would change the way it deals with innovation * Kidney device makers get more interaction with FDA * Medicare spent $29 billion on kidney disease in 2009 By Anna Yukhananov WASHINGTON, April 9 (Reuters) - Three experimental kidney devices may reach patients sooner under a plan from the U.S. Food and Drug Administration that would change the way the agency deals with medical innovation. The three devices are all novel technologies that treat end-stage renal disease, or progressive kidn” View full resource at huffingtonpost.com
Most Recently Shared on April 20, 2012 at 1:28 pm By:
hospital 2020 Health Organization
Medical Innovation Program Starts With The Kidneys http://t.co/lHLKWgH3 via @HuffingtonPost
U.S. Marshals seize contaminated ultrasound gel of Pharmaceutical Innovations
news-medical.net — “U.S. Marshals, acting at the request of the Food and Drug Administration, have seized Other-Sonic Generic Ultrasound Transmission Gel located at Pharmaceutical Innovations Inc. in Newark, N.J., after an FDA analysis found that product samples contained dangerous bacteria. The seizure included all lots of the gel product manufactured between June 2011 and December 2011.” View full resource at news-medical.net
Most Recently Shared on April 19, 2012 at 10:18 am By:
U.S. Marshals seize contaminated ultrasound gel of Pharmaceutical Innovations: U.S. Marshals, acting at the requ... http://t.co/T7fgLILg
Bayer receives FDA clearance for new blood glucose monitoring system
news-medical.net — “Bayer HealthCare today announced that the U.S. Food and Drug Administration (FDA) has cleared its CONTOUR Next EZ, a new blood glucose monitoring (BGM) system for use in the United States.” View full resource at news-medical.net
Most Recently Shared on April 19, 2012 at 10:11 am By:
Diabetes News: Bayer receives FDA clearance for new blood glucose monitoring system: Bayer HealthCare today anno... http://t.co/Ewow2VQK
Medgenics seeks IND approval to initiate EPODURE Biopump Phase IIb anemia study in ESRD patients
news-medical.net — “Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed an Investigational New Drug application with the U.S. Food and Drug Administration to initiate a Phase IIb multi-center, 100-patient clinical trial.” View full resource at news-medical.net
Most Recently Shared on April 18, 2012 at 4:01 pm By:
Diabetes News: Medgenics seeks IND approval to initiate EPODURE Biopump Phase IIb anemia study in ESRD patients:... http://t.co/ol32Ok8K
BIO Submits Comments on FDA Draft Guidances on Biosimilars | EON: Enhanced Online News
eon.businesswire.com — “The Biotechnology Industry Organization (BIO) submitted comments yesterday to the U.S. Food and Drug Administration (FDA) on three draft guidance docu” View full resource at eon.businesswire.com
Most Recently Shared on April 17, 2012 at 4:14 pm By:
Scott Strumello Patient Expert
BIO Submits Comments on FDA Draft Guidances on Biosimilars http://t.co/hxkvfbKU via @EONpr
Advertisement
